Menzel Garry E

Menzel Garry E is listed in filings as Director at Stoke Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2025, including 2 public disclosures. Recent filings connect the profile to Stoke Therapeutics, Inc. (STOK) and Adaptimmune Therapeutics plc (ADAPY). The current snapshot covers public activity from Jul 1, 2024 to Jun 4, 2025. Reported amounts are shown as $324.2K to $179.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.